 ABT-770 shows anticancer activity in animal models, but it is easily metabolised to an amine metabolite that causes phospholipidosis.MMI-166 has shown anticancer activity in numerous animal models, but there is no data available of its clinical performance.Prinomastat on the other hand, is one of the best studied MMP inhibitors.